Beneficial effect of deletion variant of hepatocyte growth factor for impaired hepatic regeneration in the ischemically damaged liver

World Journal of Surgery

Volumn 26, Issue 10, 2002, Pages 1260-1266

  Okamoto, Kazuya ^a   Suzuki, Shohachi ^a   Kurachi, Kiyotaka ^a   Sunayama, Kenichi ^a   Yokoi, Yoshihiro ^a   Konno, Hiroyuki ^a   Baba, Satoshi ^a   Nakamura, Satoshi ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BROMODEOXYCYTIDINE; DRUG VEHICLE; SCATTER FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; DELETION MUTANT; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; HISTOPATHOLOGY; LIVER CONGESTION; LIVER ISCHEMIA; LIVER NECROSIS; LIVER REGENERATION; LIVER RESECTION; LIVER SINUSOID; LIVER TRANSPLANTATION; LIVER WEIGHT; MALE; MICROCIRCULATION; NONHUMAN; RAT; REPERFUSION INJURY; ANIMAL; ARTICLE; BLOOD; GENE DELETION; GENETICS; LIVER; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; ASPARTATE AMINOTRANSFERASES; GENE DELETION; HEPATECTOMY; HEPATOCYTE GROWTH FACTOR; LIVER; LIVER REGENERATION; MALE; MICROCIRCULATION; MODELS, ANIMAL; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 0036777139     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-002-6587-y     Document Type: Conference Paper

References (50)

1. Yamaoka Y, Morimoto T, Inamoto T, et al. Safety of the donor in living-related liver transplantation-analysis of 100 parental donors. Transplantation 1995;59:224-226
2. Yanaga K, Kakizoe S, Ikeda T, et al. Procurement of liver allografts from non-heart-beating donors. Transplant. Proc. 1990;22:275-278
3. Takada Y, Taniguchi H, Fukunaga K, et al. Hepatic allograft procurement from non-heart-beating donors. Limits of warm ischemia in porcine liver transplantation. Transplantation 1997;63:369-373
4. Leishman RA, Varga C. Maximizing liver transplantation from non-heart-beating donors. Prog. Transplant. 2000;10:77-80
5. Azoulay D, Astarcioglu I, Bismuth H, et al. Split liver transplantation. The Paul Brousse policy. Ann. Surg. 1996;224:737-748
6. Mirza DF, Achilleos O, Pirenne J, et al. Encouraging results of split-liver transplantation. Br. J. Surg. 1998;85:494-497
7. Sakr MF, Zetti GM, Hassanein TI, et al. FK 506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats. Hepatology 1991;13:947-951
8. Selzner M, Camargo CA, Clavien P. Ischemia impairs liver regeneration after major tissue loss in rodents: protective effects of interleukin-6. Hepatology 1999;30:469-475
9. Hamanoue M, Kawaida K, Takao S, et al. Rapid and marked induction of hepatocyte growth factor during liver regeneration after ischemic or crush injury. Hepatology 1992;16:1485-1492
10. Balitho G, Engelbrecht G, Lotz Z, et al. Liver regeneration after hepatic ischemia and reduced liver autotransplantation in the rat. Hepatology 1993;17:273-279
11. Iwanami K, Takeyoshi I, Ohwada S, et al. The effect of Lazaroid U-74389G on extended liver resection with ischemia in dogs. Surgery 1999;126:908-917
12. Nakamura T, Teramoto H, Ichihara A. Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc. Natl. Acad. Sci. USA. 1986;83:6489-6493
13. Gherardi E, Gray J, Stoker M, et al. Purification of scatter factor, a fibroblast-derived basic protein that modulates epithelial interactions and movement. Proc. Natl. Acad. Sci. USA. 1989;86:5844-5848
14. Montesano R, Schaller G, Orci L. Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors. Cell 1991;66:697-711
15. Lindroos PM, Zarnegar R, Michalopoulos GK. Hepatocyte growth factor (hepatopoietin A) rapidly increases in plasma before DNA synthesis and liver regeneration stimulated by partial hepatectomy and carbon tetrachloride administration. Hepatology 1991;13:743-749
16. Ishiki Y, Ohnishi H, Muto Y, et al. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology 1992;16:1227-1235
17. Kosai K, Matsumoto K, Funakoshi H, et al. Hepatocyte growth factor prevents endotoxin-induced lethal hepatic failure in mice. Hepatology 1999;30:151-159
18. Kondo H, Tani T, Kodama M. Effects of deletion-type human hepatocyte growth factor on murine septic model. J. Surg. Res. 1999;85:88-95
19. Shima N, Tsuda E, Goto M, et al. Hepatocyte growth factor and its variant with a deletion of five amino acids are distinguishable by their biological activity and tertiary structure. Biochem. Biophys. Res. Commun. 1994;200:808-815
20. Suzuki S, Nakamura S, Sakaguchi T, et al. Pathophysiological appraisal of a rat model of total hepatic ischemia with an extracorporeal portosystemic shunt. J. Surg. Res. 1998;80:22-27
21. Higgins GM, Anderson RM. Experimental pathology for the liver. Restoration of the liver of the white rat following partial surgical removal. Arch. Pathol. 1931;12:186-202
22. Ellwart J, Dörmer P. Effect of 5-fluoro-2′-deoxyuridine (FdUrd) on 5-bromo-2′-deoxyuridine (BrdUrd) incorporation into DNA measured with a monoclonal BrdUrd antibody and by the BrdUrd/Hoechst quenching effect. Cytometry 1985;6:513-520
23. Yamada A, Matsumoto K, Iwanari H, et al. Rapid and sensitive enzyme-linked immunosorbent assay for measurement of HGF in rat and human tissues. Biomed. Res. 1995;16:105-114
24. Kootstra G. Statement of non-heart-beating donor programs. Transplant. Proc. 1995;27:2965
25. Kauffman HM, Bennett LE, McBride MA, et al. The expanded donor. Transplant. Rev. 1997;11:165-190
26. Reich DJ, Munoz SJ, Rothstein KD, et al. Controlled non-heart-beating donor liver transplantation. A successful single center experience, with topic update. Transplantation 2000;70:1159-1166
27. D'Alessandro AM, Hoffmann RM, Knechtle SJ, et al. Liver transplantation from controlled non-heart beating donors. Surgery 2000;128:579-588
28. Greig PD, Woolf GM, Sinclair SB, et al. Treatment of primary liver graft nonfunction with prostaglandin E1. Transplantation 1989;48:447-453
29. Huguet C, Gavelli A, Chieco PA, et al. Liver ischemia for hepatic resection: where is the limit? Surgery 1992;111:251-259
30. Nagasue N, Yukaya H, Suehiro S, et al. Tolerance of the cirrhotic liver to normothermic ischemia. A clinical study of 15 patients. Am. J. Surg. 1984;147:772-775
31. Masson S, Daveau M, Hiron M, et al. Differential regenerative response and expression of growth factors following hepatectomy of variable extent in rats. Liver 1999;19:312-317
32. Maruyama H, Harada A, Kurokawa T, et al. Duration of liver ischemia and hepatic regeneration after hepatectomy in rats. J. Surg. Res. 1995;58:290-294
33. Suzuki S, Nakamura S, Sakaguchi T, et al. Alteration of reticuloendothelial phagocytic function and tumor necrosis factor-α production after total hepatic ischemia. Transplantation 1997;64:821-827
34. Yanaga K, Kishikawa K, Suehiro T, et al. Partial hepatic grafting: porcine study on critical volume reduction. Surgery 1995;118:486-492
35. Fujiwara K, Nagoshi S, Ohno A, et al. Stimulation of liver growth by exogenous human hepatocyte growth factor in normal and partially hepatectomized rats. Hepatology 1993;18:1443-1449
36. Kaido T, Seto S, Yamaoka S, et al. Perioperative continuous hepatocyte growth factor supply prevents postoperative liver failure in rats with liver cirrhosis. J. Surg. Res. 1998;74:173-178
37. Noji S, Tashiro K, Koyama E, et al. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem. Biophys. Res. Commun. 1990;173:42-47
38. Ramandori G, Neubauer K, Odenthal M, et al. The gene of hepatocyte growth factor is expressed in fat-storing cells of rat liver and is downregulated during cell growth and by transforming growth factor-beta. Biochem. Biophys. Res. Commun. 1992;183:739-742
39. Yanagita K, Nagaike M, Ishibashi H, et al. Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem. Biophys. Res. Commun. 1992;182:802-809
40. Zarnegar R, DeFrances MC, Kost DP, et al. Expression of hepatocyte growth factor mRNA in regenerating rat liver after partial hepatectomy. Biochem. Biophys. Res. Commun. 1991;177:559-565
41. Jaeschke H. Mechanism of reperfusion injury after warm ischemia of the liver. J Hepatobiliary Pancreat Surg 1998;5:402-408
42. Yadav SS, Howell DN, Steeber DA, et al. P-selectin mediates reperfusion injury through neutrophil and platelet sequestration in the warm ischemic mouse liver. Hepatology 1999;29:1494-1502
43. Kohli V, Selzner M, Madden JF, et al. Endothelial cell and hepatocyte deaths occur by apoptosis after ischemia-reperfusion injury in the rat liver. Transplantation 1999;67:1099-1105
44. Takeda Y, Arii S, Kaido T, et al. Morphologic alteration of hepatocytes and sinusoidal endothelial cells in rat fatty liver during cold preservation and the protective effect of hepatocyte growth factor. Transplantation 1999;67:820-828
45. Ikegami T, Nishizaki T, Uchiyama H, et al. Experimental study of the effects of deletion variant of hepatocyte growth factor on hepatic ischaemia-reperfusion injury. Br. J. Surg. 2000;87:59-64
46. Uchiyama H, Yanaga K, Nishizaki T, et al. Effects of deletion variant of hepatocyte growth factor on reduced-size liver transplantation in rats. Transplantation 1999;68:39-44
47. Cressman DE, Greenbaum LE, DeAngelis RA, et al. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 1996;274:1379-1383
48. Kahn D, Hickman R, Dent DM, et al. For how long can the liver tolerate ischemia? Eur Surg Res 1986;18:277-282
49. Delva E, Camus Y, Nordlinger B, et al. Vascular occlusions for liver resections. Operative management and tolerance to hepatic ischemia: 142 cases. Ann Surg 1989;209:211-218
50. Kosuge K, Ishizaki M, Nemoto M, et al. A comparative study of the anatomy of rat and human livers. J Hepatobiliary Pancreat Surg 1999;6:171-175